Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9270857 | Journal of Infection | 2005 | 5 Pages |
Abstract
A decline in serum sIL-2Rα levels might be used as a marker of treatment efficacy in brucellosis.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Alexandros C. Makis, Emmanouil Galanakis, Eleftheria C. Hatzimichael, Zoe L. Papadopoulou, Antigone Siamopoulou, Konstantinos L. Bourantas,